We are living in exciting times regarding therapies for people with diabetes. Much of the excitement, for both type 1 and type 2 diabetes, is about disease modification and claims of drugs being disease modifying. But what does disease modifying mean?
In the USA, before a patient can receive certain treatments or medications, a prior authorisation from their health insurance company is needed. A new USA-wide…
Read the current issue of The Lancet Global Health, a monthly open access journal publishing robustly designed original research on all aspects of global health
Systemic juvenile idiopathic arthritis (sJIA) is a systemic autoinflammatory disease presenting in children (aged <16 years) with a spiking fever and joint inflammation, which often…
Allogeneic HSCT might be a valuable treatment option for patients with refractory sJIA and sJIA-LD and should be considered for children with worsening oxygen dependence…
In November, 2024, the UK Parliament voted to support the Terminally Ill Adults (End of Life) Bill.1 The bill would allow terminally ill adults with…
Radioiodine therapy was non-inferior to no radioiodine therapy after thyroidectomy among patients with low-risk differentiated thyroid cancer.
Since the COVID-19 pandemic, considerable advances have been made to improve epidemic preparedness by accelerating diagnostics, therapeutics, and vaccine development. However, we argue that it…
In this Review, we aim to complement the 2023 update of the guidelines of the International Working Group on the Diabetic Foot. We highlight the…
Despite the diverse nature of obesity, there is compelling genetic, clinical, and experimental evidence that endorses the important contribution of brain circuits to this condition.…
